BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 24990184)

  • 1. Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging.
    Bailey RA; Wang Y; Zhu V; Rupnow MF
    BMC Res Notes; 2014 Jul; 7():415. PubMed ID: 24990184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic kidney disease among US adults with type 2 diabetes and cardiovascular diseases: A national estimate of prevalence by KDIGO 2012 classification.
    Wang T; Xi Y; Lubwama R; Hannanchi H; Iglay K; Koro C
    Diabetes Metab Syndr; 2019; 13(1):612-615. PubMed ID: 30641775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult population.
    Ji E; Kim YS
    Korean J Intern Med; 2016 Nov; 31(6):1120-1130. PubMed ID: 27017386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Albuminuria and GFR Among Adolescents in the United States, 1988-2014.
    Saydah SH; Xie H; Imperatore G; Burrows NR; Pavkov ME
    Am J Kidney Dis; 2018 Nov; 72(5):644-652. PubMed ID: 30017204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease: an analysis of the German DPV and DIVE databases.
    Bramlage P; Lanzinger S; van Mark G; Hess E; Fahrner S; Heyer CHJ; Friebe M; Seufert J; Danne T; Holl RW
    Cardiovasc Diabetol; 2019 Mar; 18(1):33. PubMed ID: 30878037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes.
    Nichols GA; Déruaz-Luyet A; Brodovicz KG; Kimes TM; Rosales AG; Hauske SJ
    BMC Nephrol; 2020 May; 21(1):167. PubMed ID: 32380961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cardiovascular disease burden and therapeutic goal attainment in US adults with chronic kidney disease: an analysis of national health and nutritional examination survey data, 2001-2010.
    Kuznik A; Mardekian J; Tarasenko L
    BMC Nephrol; 2013 Jun; 14():132. PubMed ID: 23802885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between albuminuric CKD and diabetic retinopathy in a real-world setting of type 2 diabetes: Findings from No blind study.
    Sasso FC; Pafundi PC; Gelso A; Bono V; Costagliola C; Marfella R; Sardu C; Rinaldi L; Galiero R; Acierno C; Caturano A; de Sio C; De Nicola L; Salvatore T; Nevola R; Adinolfi LE; Minutolo R;
    Nutr Metab Cardiovasc Dis; 2019 Sep; 29(9):923-930. PubMed ID: 31377186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Descriptive study of the economic burden among patients with type 2 diabetes mellitus, chronic kidney disease, and chronic kidney disease and type 2 diabetes mellitus in a large US commercially insured population.
    Chung H; Crowe CL; Kong SX; Singh R; Farej R; Elliott J; Williamson T; Willey VJ
    J Manag Care Spec Pharm; 2023 Jan; 29(1):80-89. PubMed ID: 36580126
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effectiveness of Pneumococcal Vaccination Among Patients With CKD in the United States.
    Ishigami J; Padula WV; Grams ME; Chang AR; Jaar B; Gansevoort RT; Bridges JFP; Kovesdy CP; Uchida S; Coresh J; Matsushita K
    Am J Kidney Dis; 2019 Jul; 74(1):23-35. PubMed ID: 30898360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and risk factors for chronic kidney disease in primary health care in the southern region of New Zealand.
    Lloyd H; Li G; Tomlin A; Tilyard MW; Walker R; Schollum J
    Nephrology (Carlton); 2019 Mar; 24(3):308-315. PubMed ID: 29717528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program.
    Neuen BL; Ohkuma T; Neal B; Matthews DR; de Zeeuw D; Mahaffey KW; Fulcher G; Blais J; Li Q; Jardine MJ; Perkovic V; Wheeler DC
    Am J Kidney Dis; 2021 Jan; 77(1):23-34.e1. PubMed ID: 32971190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes and CKD in the United States Population, 2009-2014.
    Zelnick LR; Weiss NS; Kestenbaum BR; Robinson-Cohen C; Heagerty PJ; Tuttle K; Hall YN; Hirsch IB; de Boer IH
    Clin J Am Soc Nephrol; 2017 Dec; 12(12):1984-1990. PubMed ID: 29054846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of chronic kidney disease and associated factors in Chinese individuals with type 2 diabetes: Cross-sectional study.
    Guo K; Zhang L; Zhao F; Lu J; Pan P; Yu H; Bao Y; Chen H; Jia W
    J Diabetes Complications; 2016 Jul; 30(5):803-10. PubMed ID: 27068269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey.
    Coresh J; Astor BC; Greene T; Eknoyan G; Levey AS
    Am J Kidney Dis; 2003 Jan; 41(1):1-12. PubMed ID: 12500213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and outcomes of KDIGO-defined chronic kidney disease in 1.4 million U.S. Veterans with heart failure.
    Patel SS; Raman VK; Zhang S; Deedwania P; Zeng-Treitler Q; Wu WC; Lam PH; Bakris G; Moore H; Heidenreich PA; Rangaswami J; Morgan CJ; Cheng Y; Sheriff HM; Faselis C; Mehta RL; Anker SD; Fonarow GC; Ahmed A
    Eur J Heart Fail; 2024 May; 26(5):1251-1260. PubMed ID: 38700246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease.
    Chu CD; Xia F; Du Y; Singh R; Tuot DS; Lamprea-Montealegre JA; Gualtieri R; Liao N; Kong SX; Williamson T; Shlipak MG; Estrella MM
    JAMA Netw Open; 2023 Jul; 6(7):e2326230. PubMed ID: 37498594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden of Chronic Kidney Disease by KDIGO Categories of Glomerular Filtration Rate and Albuminuria: A Systematic Review.
    Murton M; Goff-Leggett D; Bobrowska A; Garcia Sanchez JJ; James G; Wittbrodt E; Nolan S; Sörstadius E; Pecoits-Filho R; Tuttle K
    Adv Ther; 2021 Jan; 38(1):180-200. PubMed ID: 33231861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Obesity and Chronic Kidney Disease, Defined by Both Glomerular Filtration Rate and Albuminuria, in Korean Adults.
    Kim YJ; Hwang SD; Oh TJ; Kim KM; Jang HC; Kimm H; Kim HC; Jee SH; Lim S
    Metab Syndr Relat Disord; 2017 Oct; 15(8):416-422. PubMed ID: 28832275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.